John W Kozarich's Net Worth
$4.97 Million
Who is John W Kozarich?
John W Kozarich has an estimated net worth of $4.97 Million. This is based on reported shares across multiple companies, which include Corium International, Inc., Retrophin, Inc., Intec Pharma Ltd., LIGAND PHARMACEUTICALS INC, and QLT INC/BC.
SEC CIK
John W Kozarich's CIK is 0001223000
Past Insider Trading and Trends
2014 was John W Kozarich's most active year for acquiring shares with 11 total transactions. John W Kozarich's most active month to acquire stocks was the month of May. 2015 was John W Kozarich's most active year for disposing of shares, totalling 4 transactions. John W Kozarich's most active month to dispose stocks was the month of April. 2023 saw John W Kozarich paying a total of $120,598.56 for 13,011 shares, this is the most they've acquired in one year. In 2023 John W Kozarich cashed out on 17,260 shares for a total of $833,708.68, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Corium International, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Retrophin, Inc. (TVTX) Snapshot price: $10.98
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +7.41% | 2K |
—
|
—
| 29K |
May 8
| |||
Form 4
| +10.20% | 2.5K |
—
|
—
| 27K |
May 9
| |||
Form 4
| +11.36% | 2.5K |
—
|
—
| 24.5K |
May 17
| |||
Form 4
| +10.00% | 2K |
—
|
—
| 22K |
May 18
| |||
Form 4
|
∞
| 20K |
—
|
—
| 20K |
Apr 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Intec Pharma Ltd. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 15
| |||
Form 4
| +193.20% | 100K |
$0.46 | $45,900.00 | 151.76K |
Aug 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
LIGAND PHARMACEUTICALS INC (LGND) Snapshot price: $101.14
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +2.94% | 1.25K |
—
|
—
| 43.77K |
Jun 14
| |||
Form 4
| +7.30% | 2.89K |
$39.35 | $113,839.55 | 42.52K |
Apr 24
| |||
Form 4
| +2.97% | 1.14K |
—
|
—
| 39.63K |
Jun 9
| |||
Form 4
| -10.35% | -4.44K |
$77.20 | -$343,080.80 | 38.49K |
May 16
| |||
Form 4
|
—
|
0
|
$47.69 | -$370,029.32 | 42.21K |
May 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 22
| |||
Form 4
| +2.44% | 1K |
—
|
—
| 42.21K |
Jun 10
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 4/A
| +4.24% | 1.67K |
$45.60 | $75,969.60 | 40.98K |
Scheduled
|
Sep 1
| ||
Form 4/A
| +36.43% | 5K |
$9.99 | $49,928.45 | 18.73K |
Feb 24 - Feb 25
| |||
Form 4/A
| +67.77% | 5K |
—
|
—
| 12.38K |
May 31
| |||
No matching records found |
QLT INC/BC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
| +78.13% | 25K |
$3.49 | $87,125.00 | 57K |
Jun 29
| |||
Form 4
| +45.45% | 10K |
—
|
—
| 32K |
Jun 7
| |||
Form 4
| +83.33% | 10K |
$3.59 | $35,925.85 | 22K |
Dec 19 - Dec 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 17
| |||
Form 4
| +20.00% | 2K |
—
|
—
| 12K |
Dec 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 15
| |||
Form 4
|
∞
| 10K |
$7.97 | $79,700.00 | 10K |
May 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |